Cedars Sinai Medical Center

Urology

Hyung J. Kim, MD practices Urology. He graduated from University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He over the years received 31 awards: "CMS Meaningful Use Stage 1 Certification", "Essay Contest, 1st place", "Winnick research award", "1st place essay- national meeting", "best of posters (national)", "best of posters- laparoscopy", "best of posters- oncology", "Scientist Award", "Young Investigator Award", "Molecular Markers Tutorial Award", "Surgeon-Scientist Award", "Clinical Research Loan Repayment Program Award", "Edwin Beer Award", "Junior Faculty Research Award", "3rd place", "Resident Achievement Award", "Resident Award", "Scholars in Urology Award", "2nd place for basic science research", "1st place for presentation of clinical research", "1st place for basic science poster presentation", "2nd place for presentation of urologic research", "1st place for presentation of urologic research", "Pritzker Research Award", "Student Summer Research Award", "Graduation with High Honor", "Graduation with Highest Distinction", "James B. Angell Scholar", "Phi Beta Kappa", "Sigma Xi" and "Barry Goldwater Nominee". Hyung J. Kim is a published doctor and has 27 publications published. The lastest was: 'A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).'

Publications

---

• A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance).
• Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
• Increased Number of White Matter Lesions in Patients with Familial Cerebral Cavernous Malformations.
• Learning Curves for Robot-Assisted and Laparoscopic Partial Nephrectomy.
• Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis.
• The potential role for neoadjuvant therapy in renal cell carcinoma.
• Initial experience with arterial spin-labeling MR imaging to assess histology of renal masses.
• Evaluation of a high-throughput, microfluidics platform for performing TaqMan qPCR using formalin-fixed paraffin-embedded tumors.
• A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.
• Safety and outcomes of surgical treatment of renal cell carcinoma in the elderly.
• Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer.
• Impact of cytoreductive nephrectomy on eligibility for systemic treatment and effects on survival: are surgical complications or disease related factors responsible?
• RENAL nephrometry score predicts surgical outcomes of laparoscopic partial nephrectomy.
• Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis facto...
• Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe.
• Simplified laparoscopic partial nephrectomy using a single-layer closure and no bolsters for renal tumors.
• Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
• Covalent crosslinking of tumor antigens stimulates an antitumor immune response.
• Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.
• Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma.
• The learning curve for robot-assisted radical cystectomy.
• A method for using life tables to estimate lifetime risk for prostate cancer death.
• Maximizing RNA yield from archival renal tumors and optimizing gene expression analysis.
• Impact of previous abdominal surgery on robot-assisted radical cystectomy.
• Outcomes of laparoscopic partial nephrectomy after fellowship training.
• Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.

Schools

---

• Johns Hopkins University School of Medicine

Doctors Specialties

---

• Internal Medicine
• Urology

Accepted Insurances

---

• Aetna
• Assurant Health
• Blue Card PPO
• Blue Cross Blue Shield of Illinois PPO
• Cigna
• Commercial Insurance Company
• Coventry Health Care
• Golden Rule
• Mail Handlers Benefit Plan (MHBP)
• MedHealthInsurance
• Medicare MCR
• POMCO Group
• Tricare
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• United Healthcare

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Essay Contest, 1st place
• Winnick research award
• 1st place essay- national meeting
• best of posters (national)
• best of posters- laparoscopy
• best of posters- oncology
• Scientist Award
• Young Investigator Award
• Molecular Markers Tutorial Award
• Surgeon-Scientist Award
• Clinical Research Loan Repayment Program Award
• Edwin Beer Award
• Junior Faculty Research Award
• 3rd place
• Resident Achievement Award
• Resident Award
• Scholars in Urology Award
• 2nd place for basic science research
• 1st place for presentation of clinical research
• 1st place for basic science poster presentation
• 2nd place for presentation of urologic research
• 1st place for presentation of urologic research
• Pritzker Research Award
• Student Summer Research Award
• Graduation with High Honor
• Graduation with Highest Distinction
• James B. Angell Scholar
• Phi Beta Kappa
• Sigma Xi
• Barry Goldwater Nominee

Education

---

• UCLA Medical Center
• University of Chicago
• University of Chicago Pritzker School of Medicine
• University of Michigan

Hospital

---

• Cedars-Sinai Medical Center

Drug Facts

---

NPI NUMBER		1891792693
NPPES Provider LastName		KIM
NPPES Provider FirstName		HYUNG
NPPES Provider ZIPCode		900486137
NPPES Provider State		CA
Specialty Description		Urology
Total Claim Count		98.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1891792693
Last Name Of The Provider	KIM
First Name Of The Provider	HYUNG
View All

Similar Doctors

---

	Dr. John M. Bockrath, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian M. O'Leary, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian P. Schmitt, MD This Doctor is OpenDoctor Recommended.
	Dr. Manju C. Joseph, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin W. Regan, MD This Doctor is OpenDoctor Recommended.
	Dr. Jean Houlihan, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul B. Lyon, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert M. Pasciak, MD This Doctor is OpenDoctor Recommended.
	Dr. Avtar S. Dhindsa, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert M. Seo, MD This Doctor is OpenDoctor Recommended.
	Dr. Ernst W. Lisek IV, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog